From molecular design to lead optimization — accelerated by AI
Enter a target protein and tune molecular properties to see AI-generated drug candidates
Generate novel drug-like molecules using diffusion models and reinforcement learning
AI identifies optimal protein targets from disease pathways and multi-omics data
Screen millions of compounds against targets in hours using GPU-accelerated docking
Iterative optimization of ADMET properties while maintaining binding affinity
Explore more from the DrugMind — AI Drug Design Platform ecosystem